RLAY

Bullish

Relay Therapeutics Inc (RLAY) Stock News & Articles

This article provides an overview of Relay Therapeutics Inc (RLAY), a biotechnology company specializing in small molecule therapies for cancer and ge...

24/7 Wall St. 1 week ago 0

Bearish

Relay Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview

Relay Therapeutics Inc is expected to report an earnings loss of 38 cents per share, according to a preview from Refinitiv. The article provides this ...

TradingView 1 week ago 0

Neutral

Relay Therapeutics (RLAY) executive sells 753 shares to cover RSU taxes

Relay Therapeutics executive Peter Rahmer sold 753 shares of common stock at $14.79 per share. This non-discretionary sale was solely to cover income ...

Stock Titan 1 week ago 0

Neutral

RLAY SEC Filings - Relay Therapeutics, Inc. 10-K, 10-Q, 8-K Forms

This page provides access to Relay Therapeutics, Inc. (RLAY) SEC filings, including 10-K annual reports, 10-Q quarterly reports, and 8-K material even...

Stock Titan 3 weeks ago 0